Skip to content

Explore EATRIS as         Login

EATRIS
  • About
        • About Eatris

        • Who we are
        • People
          • EATRIS Meets
        • Impact
        • Jobs
        • Governance
          • How to join EATRIS?
        • Legal
        • Spotlight Programme
        • Institutes
        • Countries
          • Bulgaria
          • Croatia
          • Czech Republic
          • Finland
          • France
          • Italy
          • Latvia
          • Luxembourg
          • Netherlands
          • Norway
          • Portugal
          • Slovakia
          • Slovenia
          • Spain
          • Sweden
  • Services
        • Services

        • Research Services
          • Industry–Academia collaborations
          • Support for funding applications
          • COVID-19
        • Innovation Services
          • Mentoring Services
          • Regulatory Services
          • Translational Feasibility Assessment
          • Health Technology Assessment
        • EATRIS Expert Centres
        • Self-Service Resources
          • EU Tracer Factory
          • Innovation Helpdesk
          • Innovation Management Toolbox
          • Multi-omics Toolbox (MOTBX)
          • Orphan Drug Development Guidebook (ODDG)
          • Patient Engagement Resource Centre
          • Regulatory Database (RIS)
        • Education & Training
          • Transmed Academy
  • Projects
        • Training
          • EUROPEAN JOINT PROGRAMME ON RARE DISEASES (EJP RD)
          • IMIBIC-P2Med
        • Quality & Reproducibility
          • HAPLO-iPS
          • EATRIS Quality Initiative
          • EDITSCD
          • iRISE
          • OSCARS
          • TRUSTroke
        • Personalised Medicine
          • canSERV
          • COMPASS-AI
          • EATRIS-CONNECT
          • ERDERA
          • ERICA
          • EUCAIM
          • HEAL
          • PRECISEU
          • RealiseD
          • RECOGNISED
          • REMEDi4ALL
          • SIMPATHIC
          • TRUSTroke
          • UMBRELLA
        • Research Infrastructure development
          • CANDLE
          • canSERV
          • EATRIS-CONNECT
          • ERIC Forum 2
          • iNext-Discovery
          • ISIDORe
          • RITIFI
          • Spotlight Programme
        • Industry collaborations
          • COMPASS-AI
          • ERDERA
          • GSK Hub
          • RealiseD
          • REMEDi4ALL
        • Long-term partnerships
          • Translation Together
          • EATRIS Quality Initiative
          • EU-AMRI
          • NewFound
          • Patient engagement
        • Cross-Research Infrastructure Collaboration
        • Archive of past projects
  • Platforms
        • Platforms

        • ATMP
        • Small Molecules
        • Vaccines, Inflammation and Immune Monitoring
        • Biomarkers
        • Imaging & Tracing
  • News
  • Events
  • Resources
        • EATRIS 2024 Annual Report
          • Annual Report Archive
        • Strategic Plan 2023-2026
          • Strategic Plan 2019-2022
        • Sustainability Plan 2024-2030
        • Gender Equality Plan 2022-2023
        • Advocacy Efforts
        • Publications Citing EATRIS
          • How to acknowledge EATRIS
        • FUNDING OPPORTUNITIES FOR MEMBERS
        • Brand Centre
        • Glossary, abbreviations and acronyms
        • Leaflets
          • Platform leaflets
          • Support for Funding Applications leaflet
          • Technology Leaflets
          • EATRIS One-pager
  • Contact
Countries
All Bulgaria Croatia Czech Republic Finland France Italy Latvia Luxembourg Netherlands Norway Portugal Slovakia Slovenia Spain Sweden

Countries

All Bulgaria Croatia Czech Republic Finland France Italy Latvia Luxembourg Netherlands Norway Portugal Slovakia Slovenia Spain Sweden
5 May 2025
 

EATRIS Services Now Featured in the European Innovation Council (EIC) Service Catalogue

28 April 2025
 

New Publication Highlights EATRIS Contribution to Multi-Omics Standards in Phenomics

15 April 2025
 

EATRIS Leads Strategic Mapping of ATMP Capacities Across Europe through PRECISEU

27 March 2025
 

University of Coimbra Launches €5M Gene Therapy Innovation Hub to Accelerate Gene Therapy Development Across Europe

26 March 2025
 

Florence Bietrix Appointed Section Editor for the Journal of Translational Medicine

25 March 2025
 

EATRIS Portugal Governor Rui Santos Ivo Elected Chair of EMA’s Management Board

24 March 2025
 

EATRIS Guest Edits Cell & Gene Therapy Insights Special Issue on Expanding Cellular Immunotherapy

21 March 2025
 

REMEDi4ALL featured in NYT article on AI and drug repurposing

12 March 2025
 

EATRIS co-signs the European Health Data Space (EHDS) Multi-Stakeholder Statement

5 March 2025
 

Launch of the PEARLDIVER Platform Trial for drug development and repurposing in Major Depressive Disorder

12 February 2025
 

European Commission launches new “Biotech and Biomanufacturing Hub” to support innovative companies

10 February 2025
 

New depression trial will use EU-PEARL study designs

27 January 2025
 

EMA Offers Fee Waivers for Scientific Advice to Support Public Health Research

23 January 2025
 

Concluding the Journey of the EATRIS-GSK Imaging Hub

8 January 2025
 

Anton Ussi Confirmed as EATRIS Operations & Finance Director for a Further Five Years

17 December 2024
 

Launch of New Handbook for ATMP Developers

10 December 2024
 

Sweden in the Spotlight: AI in healthcare

25 November 2024
 

TMex 2024: advancing the future of medicine together

Posts navigation

Older posts
Newer posts

Sign up for news and updates

By signing up, you agree to our Privacy Policy

EATRIS ERIC logo

EATRIS ERIC
De Boelelaan 1117
1081 HV Amsterdam
The Netherlands

T +31 20 444 2254
E info@eatris.eu

WITH THANKS TO OUR FUNDERS AND PARTNERS




© Copyright EATRIS ERIC | Privacy Policy | EATRIS ERIC Statutes | EATRIS ERIC was established by Commission Implementing Decision 2013/640/EU of 7 November 2013